                         SEQUENCE LISTING

<110>  Ramot at Tel-Aviv University Ltd.
       SATCHI-FAINARO, Ronit
       FLORINDO, Helena
       CONNIOT, Joao
       SCOMPARIN, Anna
 
<120>  POLYMERIC NANOVACCINES AND USES THEREOF

<130>  79659

<150>  62/785,715
<151>  2018-12-28

<150>  62/869,591
<151>  2019-07-02

<160>  28    

<170>  PatentIn version 3.5

<210>  1
<211>  10
<212>  PRT
<213>  Artificial sequence

<220>
<223>  disease-associated antigen amino acid sequence

<400>  1

Glu Leu Ala Gly Ile Gly Ile Leu Thr Val 
1               5                   10  


<210>  2
<211>  23
<212>  PRT
<213>  Artificial sequence

<220>
<223>  disease-associated antigen amino acid sequence

<400>  2

Arg Asn Gly Tyr Arg Ala Leu Met Asp Lys Ser Leu His Val Gly Thr 
1               5                   10                  15      


Gln Cys Ala Leu Thr Arg Arg 
            20              


<210>  3
<211>  20
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Examples of CpG oligodeoxynucleotide nucleic acid sequrnce

<400>  3
tccatgacgt tcctgacgtt                                                   20


<210>  4
<211>  10
<212>  PRT
<213>  Artificial sequence

<220>
<223>  disease-associated antigen amino acid sequence

<400>  4

Val Val Arg His Cys Pro His His Glu Arg 
1               5                   10  


<210>  5
<211>  10
<212>  PRT
<213>  Artificial sequence

<220>
<223>  disease-associated antigen amino acid sequence

<400>  5

Glu Val Val Arg His Cys Pro His His Glu 
1               5                   10  


<210>  6
<211>  9
<212>  PRT
<213>  Artificial sequence

<220>
<223>  disease-associated antigen amino acid sequence

<400>  6

Ala Ala Leu Leu Asn Lys Leu Tyr Ala 
1               5                   


<210>  7
<211>  9
<212>  PRT
<213>  Artificial sequence

<220>
<223>  disease-associated antigen amino acid sequence

<400>  7

Glu Gly Ser Arg Asn Gln Asp Trp Leu 
1               5                   


<210>  8
<211>  16
<212>  PRT
<213>  Artificial sequence

<220>
<223>  disease-associated antigen amino acid sequence

<400>  8

Trp Asn Arg Gln Leu Tyr Pro Glu Trp Thr Glu Ala Gln Arg Leu Asp 
1               5                   10                  15      


<210>  9
<211>  27
<212>  PRT
<213>  Artificial sequence

<220>
<223>  disease-associated antigen amino acid sequence

<400>  9

Pro Ser Lys Pro Ser Phe Gln Glu Phe Val Asp Trp Glu Asn Val Ser 
1               5                   10                  15      


Pro Glu Leu Asn Ser Thr Asp Gln Pro Phe Leu 
            20                  25          


<210>  10
<211>  27
<212>  PRT
<213>  Artificial sequence

<220>
<223>  disease-associated antigen amino acid sequence

<400>  10

Glu Phe Lys His Ile Lys Ala Phe Asp Arg Thr Phe Ala Asn Asn Pro 
1               5                   10                  15      


Gly Pro Met Val Val Phe Ala Thr Pro Gly Met 
            20                  25          


<210>  11
<211>  8
<212>  PRT
<213>  Artificial sequence

<220>
<223>  disease-associated antigen amino acid sequence

<400>  11

Ser Ile Ile Asn Phe Glu Lys Leu 
1               5               


<210>  12
<211>  17
<212>  PRT
<213>  Artificial sequence

<220>
<223>  disease-associated antigen amino acid sequence

<400>  12

Ile Ser Gln Ala Val His Ala Ala His Ala Glu Ile Asn Glu Ala Gly 
1               5                   10                  15      


Arg 
    


<210>  13
<211>  15
<212>  PRT
<213>  Artificial sequence

<220>
<223>  disease-associated antigen amino acid sequence

<400>  13

Gly Asp Phe Gly Leu Ala Thr Glu Lys Ser Arg Trp Ser Gly Ser 
1               5                   10                  15  


<210>  14
<211>  9
<212>  PRT
<213>  Artificial sequence

<220>
<223>  disease-associated antigen amino acid sequence

<400>  14

Tyr Leu Ser Gly Ala Asp Leu Asn Leu 
1               5                   


<210>  15
<211>  9
<212>  PRT
<213>  Artificial sequence

<220>
<223>  disease-associated antigen amino acid sequence

<400>  15

Ala Ser Met Thr Asn Met Glu Leu Met 
1               5                   


<210>  16
<211>  28
<212>  PRT
<213>  Artificial sequence

<220>
<223>  disease-associated antigen amino acid sequence

<400>  16

Gly Ile Pro Val His Leu Glu Leu Ala Ser Met Thr Asn Met Glu Leu 
1               5                   10                  15      


Met Ser Ser Ile Val His Gln Gln Val Phe Pro Thr 
            20                  25              


<210>  17
<211>  17
<212>  PRT
<213>  Artificial sequence

<220>
<223>  disease-associated antigen amino acid sequence

<400>  17

Lys Leu Val Val Val Gly Ala Gly Gly Val Gly Lys Ser Ala Leu Thr 
1               5                   10                  15      


Ile 
    


<210>  18
<211>  17
<212>  PRT
<213>  Artificial sequence

<220>
<223>  disease-associated antigen amino acid sequence

<400>  18

Lys Leu Val Val Val Gly Ala Asp Gly Val Gly Lys Ser Ala Leu Thr 
1               5                   10                  15      


Ile 
    


<210>  19
<211>  15
<212>  PRT
<213>  Artificial sequence

<220>
<223>  disease-associated antigen amino acid sequence

<400>  19

Ser Ala Leu Thr Ile Gln Leu Ile Gln Asn His Phe Val Asp Glu 
1               5                   10                  15  


<210>  20
<211>  15
<212>  PRT
<213>  Artificial sequence

<220>
<223>  disease-associated antigen amino acid sequence

<400>  20

Phe Leu Cys Val Phe Ala Ile Asn Asn Thr Lys Ser Phe Glu Asp 
1               5                   10                  15  


<210>  21
<211>  15
<212>  PRT
<213>  Artificial sequence

<220>
<223>  disease-associated antigen amino acid sequence

<400>  21

Phe Tyr Thr Leu Val Arg Glu Ile Arg Lys His Lys Glu Lys Met 
1               5                   10                  15  


<210>  22
<211>  9
<212>  PRT
<213>  Artificial sequence

<220>
<223>  disease-associated antigen amino acid sequence

<400>  22

Tyr Ile His Thr His Thr Phe Tyr Val 
1               5                   


<210>  23
<211>  9
<212>  PRT
<213>  Artificial sequence

<220>
<223>  disease-associated antigen amino acid sequence

<400>  23

Ser Gln Ile Trp Asn Leu Asn Pro Val 
1               5                   


<210>  24
<211>  9
<212>  PRT
<213>  Artificial sequence

<220>
<223>  disease-associated antigen amino acid sequence

<400>  24

Gln Ala Thr Glu Ala Glu Arg Ser Phe 
1               5                   


<210>  25
<211>  13
<212>  PRT
<213>  Artificial sequence

<220>
<223>  disease-associated antigen amino acid sequence

<400>  25

Ala Lys Phe Val Ala Ala Trp Thr Leu Lys Ala Ala Ala 
1               5                   10              


<210>  26
<211>  21
<212>  DNA
<213>  Artificial sequence

<220>
<223>  siRNA nucleic acid sequence

<400>  26
gggcuaccau gccaacuuct t                                                 21


<210>  27
<211>  21
<212>  DNA
<213>  Artificial sequence

<220>
<223>  siRNA nucleic acid sequence

<400>  27
cccacauaaa aaacaguugt t                                                 21


<210>  28
<211>  21
<212>  DNA
<213>  Artificial sequence

<220>
<223>  siRNA nucleic acid sequence

<400>  28
gaagcccaau caauaacugt t                                                 21


